Generate Biomedicines, Inc. United States of America (USA)
Research
Date range: 1 December 2020 - 30 November 2021
Region: Global
Subject/journal group: All
The table to the right includes counts of all research outputs for Generate Biomedicines, Inc. published between 1 December 2020 - 30 November 2021 which are tracked by the Nature Index.
Hover over the donut graph to view the Share for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.
Note: Articles may be assigned to more than one subject area.
Count | Share |
---|---|
1 | 0.07 |
Outputs by subject (Share)
Subject | Count | Share |
---|---|---|
Life Sciences | 1 | 0.07 |
Share output for the past 5 years
2016 | 2017 | 2018 | 2019 | 2020 |
---|---|---|---|---|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Collaboration
Date range: 1 December 2020 - 30 November 2021
International vs. domestic collaboration by Share
- 50.24% Domestic
- 49.76% International
Hover over the graph to view the percentage of collaboration.
Top 10 domestic collaborators with Generate Biomedicines, Inc. by Share (12 total)
-
Generate Biomedicines, Inc. and La Jolla Institute for Immunology (LJI)
(0.32)
-
Generate Biomedicines, Inc. and Duke University
(0.15)
-
Generate Biomedicines, Inc. and Twist Bioscience
(0.11)
-
Generate Biomedicines, Inc. and Fred Hutchinson Cancer Research Center (FHCRC)
(0.11)
-
Generate Biomedicines, Inc. and National Resilience, Inc.
(0.10)
-
Generate Biomedicines, Inc. and University of Maryland, Baltimore (UMB)
(0.10)
-
Generate Biomedicines, Inc. and Active Motif, Inc.
(0.10)
-
Generate Biomedicines, Inc. and Carterra Inc.
(0.10)
-
Generate Biomedicines, Inc. and Centivax, Inc.
(0.10)
-
Generate Biomedicines, Inc. and Columbia University in the City of New York (CU)
(0.10)
Top 10 international collaborators with Generate Biomedicines, Inc. by Share (15 total)
-
Generate Biomedicines, Inc. and Celltrion Inc.
(0.14)
-
Generate Biomedicines, Inc. and Amsterdam UMC
(0.12)
-
Generate Biomedicines, Inc. and Sanyou Biopharmaceuticals Co., Ltd.
(0.11)
-
Generate Biomedicines, Inc. and High Fidelity Biology (HiFiBiO)
(0.11)
-
Generate Biomedicines, Inc. and Shanghai Henlius Biotech, Inc.
(0.10)
-
Generate Biomedicines, Inc. and University of Amsterdam (UvA)
(0.10)
-
Generate Biomedicines, Inc. and VU Amsterdam
(0.10)
-
Generate Biomedicines, Inc. and Kymab Limited
(0.09)
-
Generate Biomedicines, Inc. and Quadrucept Bio Ltd.
(0.09)
-
Generate Biomedicines, Inc. and Myrio Therapeutics Pty, Ltd.
(0.08)

Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.